Skip to main content

Peer Review reports

From: A pancancer analysis of the carcinogenic role of receptor-interacting serine/threonine protein kinase-2 (RIPK2) in human tumours

Original Submission
7 Jan 2022 Submitted Original manuscript
Resubmission - Version 2
Submitted Manuscript version 2
21 Feb 2022 Reviewed Reviewer Report
28 Feb 2022 Reviewed Reviewer Report
12 Mar 2022 Author responded Author comments - Xiaohu Wang
Resubmission - Version 3
12 Mar 2022 Submitted Manuscript version 3
20 Mar 2022 Author responded Author comments - Xiaohu Wang
Resubmission - Version 4
20 Mar 2022 Submitted Manuscript version 4
25 Mar 2022 Reviewed Reviewer Report
28 Mar 2022 Reviewed Reviewer Report
5 Apr 2022 Author responded Author comments - Xiaohu Wang
Resubmission - Version 5
5 Apr 2022 Submitted Manuscript version 5
6 Apr 2022 Author responded Author comments - Xiaohu Wang
Resubmission - Version 6
6 Apr 2022 Submitted Manuscript version 6
10 Apr 2022 Author responded Author comments - Xiaohu Wang
Resubmission - Version 7
10 Apr 2022 Submitted Manuscript version 7
Publishing
13 Apr 2022 Editorially accepted
26 Apr 2022 Article published 10.1186/s12920-022-01239-3

You can find further information about peer review here.

Back to article page